Forsythiaside A ameliorates bleomycin‐induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.70006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Fan Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Henan University of Chinese Medicine, Zhengzhou, China. Hauptthemen laut MEDLINE: Oxidative Stress, Pulmonary Fibrosis, Bleomycin, Apoptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Major Science and Technology Project in Henan Province, The Chinese Herbal Medicine Industry Technology System of Henan Province.
Abstract (Originalsprache)
Background
Pulmonary fibrosis (PF) is a common clinically critical disease characterized by high morbidity and high mortality. Forsythiaside A (FA) is a phenylethanol glycoside component in Forsythia suspensa , which has anti‐inflammatory, antioxidant, and antiviral activities. However, the effects of FA on bleomycin (BLM)‐induced PF are unclear.
Purpose
The present study explored the role of FA in the amelioration of oxidative stress and apoptosis in BLM‐induced PF as well as the possible underlying mechanisms, in vivo and in vitro.
Methods
Network pharmacology was used to collect the effects of FA on BLM‐induced PF. Subsequently, further observation of the effects of FA on mice with PF by pulmonary pathological changes, transmission electron microscopy, real‐time polymerase chain reaction, Western blot analysis, immunofluorescence, and immunohistochemistry. An in vitro model was constructed by inducing A549 with transforming growth factor beta‐1 (TGF‐β1) to observe the effect of FA on epithelial cell apoptosis.
Results
Network pharmacology predicted signaling pathways such as IL‐17 signaling pathway and Relaxin signaling pathway. The results of in vivo studies showed that FA ameliorated BLM‐induced PF through inhibition of fibrosis, modulation of apoptosis, and oxidative stress. In addition, FA promoted TGF‐β1‐induced apoptosis in A549 cells.
Conclusions
The results of our study suggested that FA could protect mice against BLM‐induced PF by regulating oxidative stress and apoptosis as well as the Epithelial mesenchymal transition pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan University of Chinese Medicine, Zhengzhou, China.
- Henan Key Laboratory of Chinese Medicine Resources and Chemistry, Zhengzhou, China.
- Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao, Henan University of Chinese Medicine, Zhengzhou, Henan Province, China.
- Co-construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan and Education Ministry of P.R., Henan University of Chinese Medicine, Zhengzhou, China.
ORCID-Profile: Suiqing Chen
Förderung
- The Major Science and Technology Project in Henan Province
- The Chinese Herbal Medicine Industry Technology System of Henan Province
Zitieren
APA
Yang, F., Zhang, Q., Wang, X., Hu, Y., & Chen, S. (2024). Forsythiaside A ameliorates bleomycin‐induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70006
Vancouver
Yang F, Zhang Q, Wang X, Hu Y, Chen S. Forsythiaside A ameliorates bleomycin‐induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.70006
BibTeX
@article{Yang2024,
author = {Yang, Fan and Zhang, Qinqin and Wang, Xi and Hu, Yingbo and Chen, Suiqing},
title = {Forsythiaside A ameliorates bleomycin‐induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.70006}
}
EUVIMED